Min Jung Sun, Kim Dong Eon, Jin Young-Hee, Kwon Sunoh
Herbal Medicine Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea.
Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea.
J Clin Med. 2020 Jul 14;9(7):2230. doi: 10.3390/jcm9072230.
Kurarinone is a prenylated flavonone isolated from the roots of . Among its known functions, kurarinone has both anti-apoptotic and anti-inflammatory properties. Coronaviruses (CoVs), including HCoV-OC43, SARS-CoV, MERS-CoV, and SARS-CoV-2, are the causative agents of respiratory virus infections that range in severity from the common cold to severe pneumonia. There are currently no effective treatments for coronavirus-associated diseases. In this report, we examined the anti-viral impact of kurarinone against infection with the human coronavirus, HCoV-OC43. We found that kurarinone inhibited HCoV-OC43 infection in human lung fibroblast MRC-5 cells in a dose-dependent manner with an IC of 3.458 ± 0.101 μM. Kurarinone inhibited the virus-induced cytopathic effect, as well as extracellular and intracellular viral RNA and viral protein expression. Time-of-addition experiments suggested that kurarinone acted at an early stage of virus infection. Finally, we found that HCoV-OC43 infection increased the autophagic flux in MRC-5 cells; kurarinone inhibited viral replication via its capacity to impair the virus-induced autophagic flux. As such, we suggest that kurarinone may be a useful therapeutic for the treatment of diseases associated with coronavirus infection.
苦参酮是一种从[植物名称]根部分离出的异戊烯基黄酮。在其已知功能中,苦参酮具有抗凋亡和抗炎特性。冠状病毒(CoV),包括人冠状病毒OC43(HCoV-OC43)、严重急性呼吸综合征冠状病毒(SARS-CoV)、中东呼吸综合征冠状病毒(MERS-CoV)和严重急性呼吸综合征冠状病毒2(SARS-CoV-2),是呼吸道病毒感染的病原体,感染严重程度从普通感冒到重症肺炎不等。目前尚无针对冠状病毒相关疾病的有效治疗方法。在本报告中,我们研究了苦参酮对人冠状病毒HCoV-OC43感染的抗病毒作用。我们发现苦参酮以剂量依赖性方式抑制人肺成纤维细胞MRC-5中HCoV-OC43的感染,半数抑制浓度(IC)为3.458±0.101μM。苦参酮抑制病毒诱导的细胞病变效应,以及细胞外和细胞内病毒RNA及病毒蛋白表达。加药时间实验表明苦参酮在病毒感染早期起作用。最后,我们发现HCoV-OC43感染增加了MRC-5细胞中的自噬通量;苦参酮通过其损害病毒诱导的自噬通量的能力抑制病毒复制。因此,我们认为苦参酮可能是治疗冠状病毒感染相关疾病的一种有效疗法。